DePuy Orthopaedics Newswire

Comprehensive Real-Time News Feed for DePuy Orthopaedics.

Results 1 - 20 of 422 in DePuy Orthopaedics

  1. DePUY Orthopaedics Inc v. BrownRead the original story w/Photo

    Friday Apr 24 | FindLaw

    ... C. Lewis, Indianapolis, IN, Attorneys for appellees. Plaintiffs Travis Brown et al. filed suit against DePuy Orthopaedics, Inc. in Marion Superior Court, alleging injuries related to certain hip replacement equipment. DePuy moved to transfer venue ...

    Comment?

  2. Johnson & Johnson: This Is My Favorite Healthcare Dividend StockRead the original story w/Photo

    11 hrs ago | Seeking Alpha

    We are talking here about a world class company. Their operations are divided into 3 segments: Consumer includes baby care, skin care, oral care, wound care, women's health and over the counter pharmaceutical products.

    Comment?

  3. Interesting October Stock Options for Johnson & JohnsonRead the original story w/Photo

    19 hrs ago | Forbes.com

    Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the October expiration for JNJ.

    Comment?

  4. Global Medical Ceramics Market 2015-2019 - New Market Research ReportRead the original story

    Yesterday | PR-inside.com

    These inorganic and nonmetallic materials are also being used worldwide in various dental and orthopedic applications, and in the manufacture of surgical and diagnostic instruments. On the basis of materials used, these ceramics can be classified into three: bioinert, bioactive, and bioresorbable.

    Comment?

  5. Ind. Decisions - Supreme Court decides 2nd case todayRead the original story

    Friday Apr 24 | Indiana Law Blog

    In DePuy Orthopaedics, Inc. and Johnson & Johnson v. Travis Brown et al , a 7-page, 5-0 opinion, Justice Massa writes: Plaintiffs Travis Brown et al. filed suit against DePuy Orthopaedics, Inc. in Marion Superior Court, alleging injuries related to certain hip replacement equipment.

    Comment?

  6. Johnson & Johnson raises dividend 7.1% to 75 centsRead the original story w/Photo

    Thursday Apr 23 | MarketWatch

    The increase is "in recognition of our 2014 results, strong financial position and confidence in the future of Johnson & Johnson," said Chief Executive Alex Gorsky. The increased dividend, to 75 cents a share from 70 cents a share, is payable on June 9 to shareholders of record as of the close of business on May 26, the company said.

    Comment?

  7. Johnson & Johnson Lifts DividendRead the original story w/Photo

    Thursday Apr 23 | Wall Street Journal

    The increase is "in recognition of our 2014 results, strong financial position and confidence in the future of Johnson & Johnson," said Chief Executive Alex Gorsky.

    Comment?

  8. Spotlight on Award Winners: J&J's Improved Shears Decrease Packaging and Waste, Enhance PerformanceRead the original story

    Thursday Apr 23 | Environmental Leader

    In a recent Johnson & Johnson study of global health care professionals, over half of respondents said hospitals are incorporating sustainability into their purchasing decisions, and 80% said that will be the case within the next two years. The results of the study - commissioned by Johnson & Johnson and conducted by Harris Polls - reflect a growing focus on sustainability, a trend that inspired improvement on an already successful product with the launch of the Harmonic Focus+ Shears, winner of a 2015 Environmental Leader Top Product of the Year Award .

    Comment?

  9. Home Depot to phase out chemical in vinyl flooringRead the original story w/Photo

    Wednesday Apr 22 | The Virginian-Pilot

    Facing pressure from consumer groups, Home Depot said it would discontinue use of a potentially harmful chemical in its vinyl flooring by the end of the year. The retailer is asking about a half-dozen suppliers to phase out their use of ortho-phthalates, according to Stephen Holmes, a spokesman.

    Comment?

  10. Robotic surgery gets a boost from Google, Johnson JohnsonRead the original story

    Wednesday Apr 22 | Packaging World

    Ethicon, a medical device company in the Johnson & Johnson family of companies, is partnering with Google in an effort to advance surgical robotics to benefit surgeons, patients and health care systems. The companies are looking to develop new robotic tools and capabilities for surgeons and operating room professionals that integrate best-in-class medical device technology with leading-edge robotic systems, imaging and data analytics.

    Comment?

  11. Recall That Recall?Read the original story

    Wednesday Apr 22 | New Urban Legends

    I have had at least 10 friends post this FDA link to a recall about Children's Motrin, Tylenol, Benadryl, etc. Everyone seems to be panicking about a notice that appears several years old to me.

    Comment?

  12. Are These Medical Devices Safe?Read the original story w/Photo

    Monday Apr 20 | Medical Device/Diagnostic Ind.

    In late 2013, media coverage of power morcellators, a tool used during laparoscopic hysterectomies, drew attention to the controversy around the device. Patient advocates say that use of morcellators to cut up uterine tissue during the laparoscopic procedures may have spread bits of tissue containing undetected cancer, which may in turn have led to upstaging of these cancers.

    Comment?

  13. DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case...Read the original story w/Photo

    Saturday Apr 18 | PRWeb

    ... new amendment permits the claims of up to 150 plaintiffs to be combined in a single complaint. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244) "This amendment will allow DePuy Pinnacle hip lawsuits ...

    Comment?

  14. Mass. court upholds $63M judgment against maker of Children's MotrinRead the original story w/Photo

    Friday Apr 17 | Worcester Telegram & Gazette

    The highest court in Massachusetts has upheld a $63 million judgment against the manufacturer of Children's Motrin awarded to a family whose daughter developed a life-threatening disease after taking the over-the-counter medicine. A jury ruled in 2013 that the McNeil Consumer Healthcare unit of Johnson & Johnson failed to provide sufficient warnings about potential side effects.

    Comment?

  15. Massachusetts court upholds $63M judgment against J&JRead the original story w/Photo

    Friday Apr 17 | Worcester Telegram & Gazette

    The highest court in Massachusetts has upheld a $63 million judgment against the manufacturer of Children's Motrin awarded to a family whose daughter developed a life-threatening disease after taking the over-the-counter medicine. A Superior Court jury ruled in 2013 that Johnson & Johnson failed to provide sufficient warnings about the potential side effects of Motrin.

    Comment?

  16. Highlands Residents Wins Top Woman Entrepreneur AwardRead the original story w/Photo

    Friday Apr 17 | The Two River Times

    After decades of representing pharmaceutical, food, beverage and beauty care companies, she had to rebuild her small business from scratch. Her strategy was to looka for businesses poised fora growth, and to grow with them.

    Comment?

  17. SJC upholds $63m verdict in Children's Motrin caseRead the original story w/Photo

    Friday Apr 17 | Boston.com

    The highest court in Massachusetts has upheld a $63 million legal judgment against health care giant Johnson & Johnson in the case of a little girl who nearly died and was left legally blind after taking one of the country's most common household medicines, Children's Motrin. The Supreme Judicial Court issued the ruling Friday affirming a Plymouth County jury's 2013 award in the case of Samantha Reckis.

    Comment?

  18. BlackBerry's Health Initiatives Might Have Hit A WallRead the original story w/Photo

    Thursday Apr 16 | Seeking Alpha

    BBRY made a healthcare-related investment last year that many saw as a great opportunity for the company to grow its user base. With IBM and AAPL's expanded partnership, and IBM's recent partnerships, BBRY might not have much hope in the $20 billion healthcare analytics market.

    Comment?

  19. Biotech IPOs Ignite As Aduro Doubles On First DayRead the original story w/Photo

    Wednesday Apr 15 | Investor's Business Daily

    Aduro, a developer of cancer immunotherapy treatments, priced at 17 and opened at 32. It raised $119 million, pricing 7 million shares at 17. . The group, called Johnson & Johnson Innovation, indicated an interest in purchasing up to $30 million of Aduro shares at the IPO price.

    Comment?

  20. IBM's Watson to provide software for personalised healthcareRead the original story w/Photo

    Wednesday Apr 15 | New Scientist

    THE supercomputer will see you now. IBM has announced it will partner with Apple and medical device companies Johnson and Johnson and Medtronic to develop a health platform for Watson, its supercomputer designed to learn the way a human does .

    Comment?